About
Christopher E. Mason is a genomics and computational biomedicine professor at Weill Cornell Medicine, where he also directs the WorldQuant Initiative for Quantitative Prediction. He is a co-founder and Global Director of Biotia and has also been publicly identified as a co-founder and scientific leader at Onegevity/Thorne HealthTech. His public profile is strongest as a scientist-founder and research ecosystem figure spanning genomics, AI, infectious disease, precision medicine, and space biology.
Areas of interest
genomicscomputational biologybiotechartificial intelligenceprecision medicineinfectious disease diagnosticsspace biologyneurosciencelongevity